https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-start-phase-3-trial-of-adjuvanted-covid-19-vaccine-candidate/
ssbrshei mark this message contains true information
｜originally written by ssbrshei
2021/03/16 該公司有正式宣布。
References
https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-start-phase-3-trial-of-adjuvanted-covid-19-vaccine-candidate/https://www.fiercepharma.com/manufacturing/medicago-s-plant-based-production-platform-bearing-fruit-gsk-partnered-covid-shot
With plant-based manufacturing, GSK partner Medicago takes COVID-19 vaccine production into the greenhouse
During the span of the COVID-19 pandemic, mRNA vaccines have gone from being promising technology in the lab to blockbuster products in the real world. In the pandemic's second year, Medicago is hopin
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.